GV notched up an exit as cancer therapy developer Monte Rosa Therapeutics priced an upsized initial public offering at the top of its range.

Applied Materials and Arm were among the investors in RAM technology developer Spin Memory, which has elected to liquidate its assets to pay creditors.

Poste Italiane, SEB, PayPal, ABN Amro, BNP Paribas, Nordnet and Nordea are set to exit the open banking platform developer in a $2.1bn purchase by Visa.

Intel Capital-backed customer experience software provider Sprinklr floated below its range in its initial public offering.

Long-term investor Boston Scientific is paying $295m upfront for the 73% of the ablation technology developer it does not own.

LinkedIn's data streaming spinoff, Confluent, is floating above its range in an offering effectively doubling the valuation of its last funding round to over $9bn.

The Tencent-backed social media app developer was aiming to raise $198m in the offering but has withdrawn in favour of alternative financing options.

Shell, Taavura Group and Menora Mivtachim-backed Nostromo secured $13.6m through a reverse merger with publicly-listed Somoto.

Boston Scientific has acquired all remaining shares in its portfolio company Farapulse, having first invested in the University of Iowa spinout in 2014.

Eli Lilly, Johnson & Johnson and Pfizer helped drug developer TRexBio close its $59m series A round while Slack backed human resources software provider Oyster at a $475m valuation.